Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors — Stella

Home/Neoplasms, Brain/HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

View on ClinicalTrials.gov

Recruiting

Back to Neoplasms, Brain trials

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(3 sites)

United States

Children's of Alabama, Birmingham, Alabama

St. Louis Children's Hospital, St Louis, Missouri

MD Anderson Cancer Center, Houston, Texas

Key details

Phase

Early testing

Sponsor

M.D. Anderson Cancer Center

Collaborators

Cannonball Kids' Cancer Foundation, Treovir, Inc

Enrollment target

~24 participants

Started

September 2019

Primary completion

September 2026

Age range

3 Years – 21 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.